ARL5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.899820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.039800E-01
Normal-vs-Stage2
2.003200E-01
Normal-vs-Stage3
1.597560E-02
Normal-vs-Stage4
6.222200E-01
Stage1-vs-Stage2
6.878600E-01
Stage1-vs-Stage3
1.154790E-01
Stage1-vs-Stage4
7.438000E-01
Stage2-vs-Stage3
1.321230E-03
Stage2-vs-Stage4
4.501000E-01
Stage3-vs-Stage4
1.433590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.425750E-01
Normal-vs-AfricanAmerican
9.260400E-01
Normal-vs-Asian
2.957200E-01
Caucasian-vs-AfricanAmerican
6.900300E-02
Caucasian-vs-Asian
8.203400E-01
AfricanAmerican-vs-Asian
2.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.764410E-01
Normal-vs-Female
2.278800E-01
Male-vs-Female
4.036000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.556800E-01
Normal-vs-Age(41-60Yrs)
4.614800E-01
Normal-vs-Age(61-80Yrs)
1.113440E-01
Normal-vs-Age(81-100Yrs)
6.487500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.770800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.933000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.756800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.396100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.585800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.732600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.466760E-01
Normal-vs-Daily Drinker
1.299870E-02
Normal-vs-Weekly Drinker
6.918500E-02
Normal-vs-Occasional Drinker
5.134000E-01
Normal-vs-Social Drinker
3.313800E-01
Non Drinker-vs-Daily Drinker
6.526200E-02
Non Drinker-vs-Weekly Drinker
5.851600E-01
Non Drinker-vs-Occasional Drinker
2.584200E-01
Non Drinker-vs-Social Drinker
6.337000E-01
Daily Drinker-vs-Weekly Drinker
2.683000E-01
Daily Drinker-vs-Occasional Drinker
1.252350E-02
Daily Drinker-vs-Social Drinker
5.550000E-02
Weekly Drinker-vs-Occasional Drinker
1.735370E-01
Weekly Drinker-vs-Social Drinker
3.973400E-01
Occasional Drinker-vs-Social Drinker
6.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.327200E-01
Normal-vs-Grade 2
1.013350E-01
Normal-vs-Grade 3
1.331820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.080800E-01
Grade 1-vs-Grade 3
7.260200E-01
Grade 1-vs-Grade 4
2.327200E-01
Grade 2-vs-Grade 3
9.025200E-01
Grade 2-vs-Grade 4
1.013350E-01
Grade 3-vs-Grade 4
1.331820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.100380E-01
Normal-vs-NonDiabetic
1.463760E-01
Diabetic-vs-NonDiabetic
7.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.783500E-03
Normal-vs-NoPancreatitis
1.820420E-01
Pancreatitis-vs-NoPancreatitis
1.162050E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.831820E-01
Normal-vs-N1
2.163200E-01
N0-vs-N1
7.798800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.942000E-01
Normal-vs-TP53-NonMutant
2.853600E-01
TP53-Mutant-vs-TP53-NonMutant
8.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
